News

Partner companies' news

Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis
HANOVER, MD, April 05, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— April 2022 — 423 views PCSA

SAB Biotherapeutics Appoints Mark J. Ratain, MD, to the Company’s Board of Scientific Advisors
SIOUX FALLS, S.D., April 05, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics [1] ( Nasdaq: SABS [2] ), (SAB), a clinical-stage biopharmaceutical compan...
Acorn Management Partners, Administrator
— April 2022 — 461 views SABS

Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update
HANOVER, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage compa...
Acorn Management Partners, Administrator
— April 2022 — 427 views PCSA

SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results
SIOUX FALLS, S.D., March 29, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics [1] ( Nasdaq: SABS [2] ), (SAB), a clinical-stage biopharmaceutical compa...
Acorn Management Partners, Administrator
— April 2022 — 419 views SABS

Luokung Announces Acquisition of Beijing Hongda Jiutong Technology Development Co., Ltd
BEIJING, March 29, 2022 /PRNewswire/ -- *Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intellige...
Acorn Management Partners, Administrator
— March 2022 — 458 views LKCO

Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST
HANOVER, MD, March 23, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing...
Acorn Management Partners, Administrator
— March 2022 — 420 views PCSA

Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
HANOVER, MD, March 10, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— March 2022 — 438 views PCSA

Luokung Affiliate eMapgo Provides Mapping Services for Ford Smart Vehicles
BEIJING, Feb.  23 , 2022 /PRNewswire/ -- *Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intelli...
Acorn Management Partners, Administrator
— February 2022 — 429 views LKCO

Luokung to Present at FORCE Family Office Webinar
BEIJING, Feb. 16, 2022 /PRNewswire/ --* Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intellige...
Acorn Management Partners, Administrator
— February 2022 — 440 views LKCO

Luokung Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
BEIJING, Jan. 7, 2022 /PRNewswire*/ *--* Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intellig...
Acorn Management Partners, Administrator
— January 2022 — 429 views LKCO

Luokung Announces Interim Results for the Three and Nine Months Ended September 30, 2021, Reports Record Revenue of $74.9 Million for the Nine-Month Period
BEIJING, Dec. 2, 2021 /PRNewswire/ -- *Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intelligent...
Acorn Management Partners, Administrator
— December 2021 — 451 views LKCO

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives